Related Experiment Video
Updated: Jul 31, 2025
Conventional and Threshold-Tracking Transcranial Magnetic Stimulation Tests for Single-handed Operation
Published on: August 16, 2021
Medicare Benefits Schedule item numbers for transcranial magnetic stimulation (TMS): Questions arising
Saxby Pridmore1, William Pridmore2
1Department of Psychiatry, University of Tasmania, Hobart, TAS, Australia.
Objective:
Four Medicare Benefits Schedule item numbers for Transcranial Magnetic Stimulation (TMS) treatment of unresponsive MDD were declared in Australia in 2021. They are accompanied by rules/conditions. The aim is to consider these rules/conditions in light of recent research and real-world experience.
Conclusions:
While evidence supports some listed rules/conditions, others lack clinical justification and deserve to be reconsidered. These include (a) ineligibility of patients who have previously received TMS, (b) a lifetime total limit of 50 treatments, (c) a second/final course being unavailable for 4 months following the completion of the first course, and (d) the second/final course being limited to 15 treatments.
More Related Videos
14:47Author Spotlight: Combined Peripheral Nerve Stimulation and Controllable Pulse Parameter Transcranial Magnetic Stimulation to Probe Sensorimotor Control and Learning
Published on: April 21, 2023
06:05Employing Transcranial Magnetic Stimulation in a Resource Limited Environment to Establish Brain-Behavior Relationships
Published on: April 20, 2022